Developing a de novo targeted knock-in method based on in utero electroporation into the mammalian brain.
Yuji TsunekawaRaymond Kunikane TerhuneIkumi FujitaAtsunori ShitamukaiTaeko SuetsuguFumio MatsuzakiPublished in: Development (Cambridge, England) (2017)
Genome-editing technology has revolutionized the field of biology. Here, we report a novel de novo gene-targeting method mediated by in utero electroporation into the developing mammalian brain. Electroporation of donor DNA with the CRISPR/Cas9 system vectors successfully leads to knock-in of the donor sequence, such as EGFP, to the target site via the homology-directed repair mechanism. We developed a targeting vector system optimized to prevent anomalous leaky expression of the donor gene from the plasmid, which otherwise often occurs depending on the donor sequence. The knock-in efficiency of the electroporated progenitors reached up to 40% in the early stage and 20% in the late stage of the developing mouse brain. Furthermore, we inserted different fluorescent markers into the target gene in each homologous chromosome, successfully distinguishing homozygous knock-in cells by color. We also applied this de novo gene targeting to the ferret model for the study of complex mammalian brains. Our results demonstrate that this technique is widely applicable for monitoring gene expression, visualizing protein localization, lineage analysis and gene knockout, all at the single-cell level, in developmental tissues.
Keyphrases
- crispr cas
- genome editing
- copy number
- gene expression
- genome wide
- early stage
- single cell
- cancer therapy
- genome wide identification
- dna methylation
- escherichia coli
- white matter
- poor prognosis
- amino acid
- cell proliferation
- living cells
- cell cycle arrest
- drug delivery
- cerebral ischemia
- blood brain barrier
- multiple sclerosis
- single molecule
- neoadjuvant chemotherapy
- subarachnoid hemorrhage
- long non coding rna
- rectal cancer
- dna repair
- rna seq
- fluorescent probe